Menopause
Menopause
Understanding Menopause
At Exeltis, we provide tailored treatment options to support women through every stage of menopause; from perimenopause to postmenopause. Our solutions are designed for you to deliver personalised care that meets the unique needs of each patient during this natural transition.
Adverse event reporting can be found at the bottom of the page
Our
products
Educational
Content
Supporting Your Patients Throughout Their Menopausal Journey with Our Product Range
Femoston® (oestradiol/dydrogesterone)
The Femoston® range is available in sequential (Femoston®) and continuous preparations (Femoston®-conti) covering a wide range of doses (standard to ultra-low). 1-4
Gepretix® (progesterone)
Gepretix is available in 100 & 200mg soft capsules and is indicated for adjunctive use with an oestrogen in post-menopausal women with an intact uterus, as hormone replacement therapy (HRT) 5,6
Resources
Download helpful materials of our HRT portfolio designed to support you in providing the best care for your patients.
Discover other specialized areas in women’s health
Contraception
Clinical tools and up-to-date guidance to help you support patients in choosing the right contraceptive method for their needs.
Pregnancy
Access trusted tools and guidance on managing nausea and vomiting in pregnancy, helping you support women with compassion and confidence.
References: 1. Femoston® 1mg/10mg. Summary of Product Characteristics. 2. Femoston® 2/10mg. Summary of Product Characteristics. 3. Femoston®-conti 0.5mg/2.5mg. Summary of Product Characteristics. 4. Femoston®-conti 1mg/5mg. Summary of Product Characteristics. 5. Gepretix 100mg soft capsules. Summary of Product Characteristics. 6. Gepretix 200mg soft capsules. Summary of Product Characteristics. 7. Elleste Solo 1 mg Tablets. Summary of Product Characteristics. 8. Elleste Solo 2 mg Tablets. Summary of Product Characteristics. 9. Elleste Duet Conti Tablets. Summary of Product Characteristics. 10. Elleste Duet 1 mg Tablets. Summary of Product Characteristics. 11. Elleste Duet 2 mg Tablets. Summary of Product Characteristics.
Reporting Side Effects
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store. Adverse events should also be reported to Exeltis UK Limited by email to pharmacovigilance.uk@exeltis.com
